Periodic Reporting for period 2 - RESPIRNA (REpurposing lung Surfactant Protein B for Inhalation therapy with RNA therapeutics)

RNA drugs are an emerging class of therapeutics that address diseases at the genomic and/or transcriptomic level. However, their widespread clinical translation is hampered by many extra-and intracellular barriers. Most importantly, RNAs are negatively charged macromolecules...